Assya Akli

发表

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

J. Trédaniel, M. Wislez, V. Gounant, 2022, Targeted Oncology.